Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-18

FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for the amlodipine besylate and atorvastatin calcium combination product, submitted by Prasco Laboratories. This approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Atorvastatin Calcium (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)